login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Pfizer Initiates Recall of Birth Control Pills in the US
The pills, about half of which were the brand name Lo/Ovral-28 and the other half were generic norgestrel and ethinyl estradiol tablets, may be improperly arranged so that inactive pills are taken at the wrong time in the monthly cycle.
"An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence," Pfizer said in a statement.
"As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy."
The pills were manufactured and packaged by Pfizer in New York state and commercialized by Akrimax Rx Products under the Akrimax brand name in the United States.
Each packet is supposed to contain 21 active tablets and seven inactive pills.
"The cause of the inexact package counts has been identified and corrected," Pfizer spokeswoman Grace Ann Arnold told AFP.
She described the problem as a "mechanical and operator visual inspection systems failure on the packaging line."
Patients who have been taking the affected lot numbers, posted on the US Food and Drug Administration website, should notify their physician, return the product to the pharmacy and begin using a back-up form of non-hormonal birth control right away, Pfizer said.
Source-AFP
|
|
More News on: Drug Toxicity, Birth Control Pills , Vaginitis, Vasectomy, Top Ten Selling Drugs, Birth Control Patch
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Birth Control Pills
Complete Medindia Resources
|
| News Categories: |
| » | New Quality Standards in Medicines |
| » | Drug for Irregular Heartbeat Gets Green Signal |
| » | Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells |
| » | Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings |
| » | Revision in Quality Standards for Heparin |
| More Drug News | |
|
Corporate Related News |
||||||||
| » | Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nod | » | Mylan’s ANDA for Clopidogrel Tablets Gets FDA Approval | |||||
| » | Drug Marketing: Abbott Labs Fined $1.6 Billion | » | The Cancer Cell Line Encyclopedia Launched by Novartis | |||||
| » | LeGoo Maker Pluromed to be Acquired by Sanofi | » | NGOs Protest Against Novartis' Glivec Lawsuit in India | |||||
| » | Allscripts Expanding India Operations | » | Bio-Tech Medicine Proves to be Attractive for TCG Lifesciences | |||||
| Read More >> | ||||||||
